MENU
SNDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Syndax Pharmaceuticals (SNDX) Ownership - Who owns Syndax Pharmaceuticals?
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
35 Gatehouse Drive
Phone
+1 781 419-1400
Employees
184
Web
https://www.syndax.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
960.29M
P/E Ratio
N/A
Total Cash
516.31M
Projected Growth
N/A
Total Debt
1.84M
Revenue
43.72M
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash/Share
6.00
Total Debt/Equity
N/A
Revenue/Share
0.51 USD as % of share price
Fundamentals
SNDX
Capitalization
960M
P/E Ratio
N/A
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash
516M
Total Cash/Share
6.00
Total Debt
1.84M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.51%
Revenue
43.7M
ROE
N/A
Book Value
215M
P/B Ratio
4.46
Cash Flow
N/A
Earnings
-3.85
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
5.80
Current Revenue Per Employee
108923.91
Dividends Per Share - Security
N/A
EBITDA
-318.27M
Float
N/A
Float - Current
N/A
Gross Income Margin
95.58
Revenue To Assets
-55.96
Shares Held By Institutions
1.69B
Shares Outstanding - Current
86M
Total Liabilities
426M
Total Volume MTD
N/A
Value
-1
Gain YTD
-15.582
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biopharmaceuticals for novel cancer therapies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
35 Gatehouse Drive
Phone
+1 781 419-1400
Employees
184
Web
https://www.syndax.com